199 related articles for article (PubMed ID: 28758896)
1. Chemo brain or tumor brain - that is the question: the presence of extracranial tumors profoundly affects molecular processes in the prefrontal cortex of TumorGraft mice.
Kovalchuk A; Ilnytskyy Y; Rodriguez-Juarez R; Shpyleva S; Melnyk S; Pogribny I; Katz A; Sidransky D; Kovalchuk O; Kolb B
Aging (Albany NY); 2017 Jul; 9(7):1660-1676. PubMed ID: 28758896
[TBL] [Abstract][Full Text] [Related]
2. Growth of malignant extracranial tumors alters microRNAome in the prefrontal cortex of TumorGraft mice.
Kovalchuk A; Ilnytskyy Y; Rodriguez-Juarez R; Katz A; Sidransky D; Kolb B; Kovalchuk O
Oncotarget; 2017 Oct; 8(51):88276-88293. PubMed ID: 29179434
[TBL] [Abstract][Full Text] [Related]
3. Sex-specific effects of cytotoxic chemotherapy agents cyclophosphamide and mitomycin C on gene expression, oxidative DNA damage, and epigenetic alterations in the prefrontal cortex and hippocampus - an aging connection.
Kovalchuk A; Rodriguez-Juarez R; Ilnytskyy Y; Byeon B; Shpyleva S; Melnyk S; Pogribny I; Kolb B; Kovalchuk O
Aging (Albany NY); 2016 Apr; 8(4):697-711. PubMed ID: 27032448
[TBL] [Abstract][Full Text] [Related]
4. Chemo brain: From discerning mechanisms to lifting the brain fog-An aging connection.
Kovalchuk A; Kolb B
Cell Cycle; 2017 Jul; 16(14):1345-1349. PubMed ID: 28657421
[TBL] [Abstract][Full Text] [Related]
5. Growth of Triple Negative and Progesterone Positive Breast Cancer Causes Oxidative Stress and Down-Regulates Neuroprotective Transcription Factor NPAS4 and NPAS4-Regulated Genes in Hippocampal Tissues of TumorGraft Mice-an Aging Connection.
Kovalchuk A; Ilnytskyy Y; Rodriguez-Juarez R; Katz A; Sidransky D; Kolb B; Kovalchuk O
Front Genet; 2018; 9():58. PubMed ID: 29556248
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus.
Bagnall-Moreau C; Chaudhry S; Salas-Ramirez K; Ahles T; Hubbard K
Mol Neurobiol; 2019 Oct; 56(10):7159-7172. PubMed ID: 30989632
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-related cognitive impairment: mechanisms, clinical features and research perspectives.
Cascella M; Di Napoli R; Carbone D; Cuomo GF; Bimonte S; Muzio MR
Recenti Prog Med; 2018 Nov; 109(11):523-530. PubMed ID: 30565571
[TBL] [Abstract][Full Text] [Related]
8. Differential DNA methylation following chemotherapy for breast cancer is associated with lack of memory improvement at one year.
Yang GS; Mi X; Jackson-Cook CK; Starkweather AR; Lynch Kelly D; Archer KJ; Zou F; Lyon DE
Epigenetics; 2020 May; 15(5):499-510. PubMed ID: 31793401
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant administration modulates stress-induced DNA methylation and DNA methyltransferase expression in rat prefrontal cortex and hippocampus.
Sales AJ; Joca SRL
Behav Brain Res; 2018 May; 343():8-15. PubMed ID: 29378290
[TBL] [Abstract][Full Text] [Related]
10. Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.
Fumagalli C; Pruneri G; Possanzini P; Manzotti M; Barile M; Feroce I; Colleoni M; Bonanni B; Maisonneuve P; Radice P; Viale G; Barberis M
Breast Cancer Res Treat; 2012 Jul; 134(1):131-7. PubMed ID: 22228432
[TBL] [Abstract][Full Text] [Related]
11. Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.
Monsma DJ; Monks NR; Cherba DM; Dylewski D; Eugster E; Jahn H; Srikanth S; Scott SB; Richardson PJ; Everts RE; Ishkin A; Nikolsky Y; Resau JH; Sigler R; Nickoloff BJ; Webb CP
J Transl Med; 2012 Jun; 10():125. PubMed ID: 22709571
[TBL] [Abstract][Full Text] [Related]
12. Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.
Li S; Payne S; Wang F; Claus P; Su Z; Groth J; Geradts J; de Ridder G; Alvarez R; Marcom PK; Pizzo SV; Bachelder RE
Breast Cancer Res; 2015 Jul; 17(1):91. PubMed ID: 26141457
[TBL] [Abstract][Full Text] [Related]
13. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
Wargon V; Fernandez SV; Goin M; Giulianelli S; Russo J; Lanari C
Breast Cancer Res Treat; 2011 Apr; 126(2):319-32. PubMed ID: 20440553
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER/PR subtypes.
Pirouzpanah S; Taleban FA; Mehdipour P; Sabour S; Atri M
Cancer Biomark; 2018 Feb; 21(3):621-638. PubMed ID: 29278880
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced cognitive impairment (CICI): An overview of etiology and pathogenesis.
Mounier NM; Abdel-Maged AE; Wahdan SA; Gad AM; Azab SS
Life Sci; 2020 Oct; 258():118071. PubMed ID: 32673664
[TBL] [Abstract][Full Text] [Related]
18. DNA mismatch repair deficiency in breast carcinoma: a pilot study of triple-negative and non-triple-negative tumors.
Wen YH; Brogi E; Zeng Z; Akram M; Catalano J; Paty PB; Norton L; Shia J
Am J Surg Pathol; 2012 Nov; 36(11):1700-8. PubMed ID: 22992699
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.
Greville G; McCann A; Rudd PM; Saldova R
Epigenetics; 2016 Dec; 11(12):845-857. PubMed ID: 27689695
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface.
Nelson ER; Li S; Kennedy M; Payne S; Kilibarda K; Groth J; Bowie M; Parilla-Castellar E; de Ridder G; Marcom PK; Lyes M; Peterson BL; Cook M; Pizzo SV; McDonnell DP; Bachelder RE
Oncotarget; 2016 Dec; 7(51):84030-84042. PubMed ID: 27768598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
